Exploring Marine Natural Compounds: Innovative Therapeutic Candidates Against Chagas Disease Through Virtual...

Area of Science:

• Marine natural products chemistry
• Computational drug discovery
• Parasitology

Background:

• Chagas disease, a significant public health issue in Latin America, is caused by the protozoan Trypanosoma cruzi.
• Current treatments for Chagas disease have limited efficacy and significant adverse effects, necessitating the development of novel therapeutic strategies.

Purpose of the Study:

• To identify potential anti-parasitic drug candidates for Chagas disease from marine natural compounds.
• To evaluate the therapeutic potential of these compounds using virtual screening and in silico methods.

Main Methods:

• Virtual screening of marine natural compounds against key targets of Trypanosoma cruzi.
• In silico evaluation including molecular docking, drug-likeness assessment, and pharmacokinetic profiling.

Main Results:

• Chandrananimycin A, venezueline A, and dispacamide exhibited high binding affinities to T. cruzi targets.
• These compounds demonstrated favorable docking scores and met essential drug-likeness criteria.
• Pharmacokinetic analysis indicated good absorption and low predicted toxicity for the identified compounds.

Conclusions:

• Marine-derived compounds represent a promising source for novel Chagas disease therapeutics.
• Further in vitro and in vivo studies are warranted to validate these findings and explore their mechanisms of action.